PATENT CLAIM ANALYSIS

Application Number: 15755537
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["424", "190100"]

Abstract:
Provided is an application of a genetically engineered bacterium of attenuated  Salmonella typhimurium  in preparation of medicines for treating liver cancer. The bacterium is attenuated  Salmonella typhimurium  VNP20009 carrying a plasmid cloned with a methioninase gene. Also provided is a construction method of the bacterium.

Claim (Index 1):
A method for treating liver cancer, the method comprising administering a genetically engineered bacterium to a human having liver cancer, wherein the genetically engineered bacterium is attenuated  Salmonella typhimurium  VNP20009 carrying a plasmid, and the plasmid is cloned with a L-methioninase gene.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.45455
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14813338', '14766558', '14119452', '13871716', '09645415']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6920851280451195
- 35 USC 102 Novelty (BERT): 0.5666904077316219
- Combined Prediction Score: 0.6795456560137697
- Mean Citation Score: 319.3477919999999
- Max Citation Score: 440.26932
- Similarity Product: 376.4024603752613

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test